FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $772,348,000 | +837.0% | 20,503 | +323.1% | 0.00% | – |
| Q4 2020 | $82,430,000 | +172.2% | 4,846 | -24.8% | 0.00% | – |
| Q3 2020 | $30,282,000 | +443.2% | 6,443 | +604.9% | 0.00% | – |
| Q2 2020 | $5,575,000 | -76.8% | 914 | -91.4% | 0.00% | – |
| Q1 2020 | $24,076,000 | -36.8% | 10,606 | +27.9% | 0.00% | – |
| Q4 2019 | $38,074,000 | +83.5% | 8,295 | +54.9% | 0.00% | – |
| Q3 2019 | $20,751,000 | -7.2% | 5,355 | +44.4% | 0.00% | – |
| Q2 2019 | $22,365,000 | -77.2% | 3,709 | -49.4% | 0.00% | – |
| Q1 2019 | $98,195,000 | +2825.1% | 7,328 | +1929.9% | 0.00% | – |
| Q4 2018 | $3,357,000 | -83.9% | 361 | -75.9% | 0.00% | – |
| Q3 2018 | $20,880,000 | -7.5% | 1,500 | +5.0% | 0.00% | – |
| Q2 2018 | $22,577,000 | -80.7% | 1,428 | -79.0% | 0.00% | – |
| Q1 2018 | $116,910,000 | -5.6% | 6,805 | +20.4% | 0.00% | – |
| Q4 2017 | $123,848,000 | +0.6% | 5,650 | +87.8% | 0.00% | – |
| Q3 2017 | $123,057,000 | +26.6% | 3,008 | -6.8% | 0.00% | – |
| Q2 2017 | $97,165,000 | -19.0% | 3,227 | -2.7% | 0.00% | – |
| Q1 2017 | $119,946,000 | -53.3% | 3,318 | -35.3% | 0.00% | -100.0% |
| Q4 2016 | $256,964,000 | +165.9% | 5,128 | +178.5% | 0.00% | – |
| Q3 2016 | $96,634,000 | +121.7% | 1,841 | +74.7% | 0.00% | – |
| Q2 2016 | $43,583,000 | -77.9% | 1,054 | -77.8% | 0.00% | – |
| Q4 2015 | $196,794,000 | +191.7% | 4,742 | +8.2% | 0.00% | – |
| Q3 2015 | $67,470,000 | -98.8% | 4,384 | -98.1% | 0.00% | -100.0% |
| Q2 2015 | $5,862,215,000 | +73833.9% | 235,999 | +67911.2% | 0.02% | – |
| Q1 2015 | $7,929,000 | -36.6% | 347 | -67.4% | 0.00% | – |
| Q3 2014 | $12,504,000 | – | 1,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|